Specifications IGF-1 LR3:
Group: Peptides
Active Half-life: 6 – 8 hours
Subgroup: Injection/ powder
Dosage: 1 mg (1000 mcg)
Application: 20 – 100 mcg every day
Product pack: 1 vial
Retains water: Yes
Aromatization: No

Product Description: IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3)

Overview:
IGF-1 LR3 is a long-acting analogue of Insulin-Like Growth Factor-1 (IGF-1), a naturally occurring peptide hormone closely associated with the effects of Growth Hormone (GH). Engineered with structural modifications for enhanced stability and an extended half-life, IGF-1 LR3 is recognized in research and performance-focused environments for its potential role in cellular growth, recovery, nutrient utilization, and tissue regeneration.

Key Features:

* Extended half-life compared to standard IGF-1
* Enhanced biological activity and stability
* Low binding affinity to IGF-binding proteins (IGFBPs)
* Supports cellular growth and recovery processes
* Research-focused peptide compound

Potential Benefits:

* Supports Muscle Recovery: May assist in post-training tissue repair and regeneration
* Enhanced Nutrient Uptake: Promotes efficient nutrient delivery at the cellular level
* Supports Lean Muscle Development: Commonly researched for anabolic and regenerative applications
* Improved Recovery Capacity: Often included in advanced recovery protocols
* Synergistic Potential: Frequently paired with HGH-related peptide protocols

General Use Context:

* Primarily used in research and experimental peptide protocols
* Popular among individuals focused on performance optimization, regeneration, and recovery support
* Commonly studied in advanced body composition and tissue repair applications

Precautions:

* Potential Side Effects: Changes in blood glucose regulation, fatigue, headaches, or temporary water retention
* High Biological Potency: Requires careful and informed handling
* Limited long-term human research available
* Medical supervision is strongly recommended before use

Legal Status:
IGF-1 LR3 is generally sold as a research peptide and is not approved for general medical use in many countries. Regulatory status varies depending on local laws and regulations. It is prohibited by major anti-doping organizations.

Conclusion:
IGF-1 LR3 is a highly potent, long-acting peptide valued for its potential to support cellular recovery, tissue regeneration, and performance-focused goals. Due to its powerful biological activity, it should be approached with responsibility, awareness, and appropriate professional guidance.